About InVitro International
InVitro International is a company based in Irvine (United States) founded in 1996. The company has 6 employees as of September 30, 2024. InVitro International offers products and services including IRRITECTION Assay System, Corrositex, and Lab Services. InVitro International operates in a competitive market with competitors including Nautilus Biotechnology, Somalogic, ProteinSimple, Amunix and Dynamic Biosensors, among others.
- Headquarter Irvine, United States
- Employees 6 as on 30 Sep, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Invitro International
-
Annual Revenue
$878.94 K (USD)8.34as on Sep 30, 2025
-
Net Profit
$121.98 K (USD)14.32as on Sep 30, 2025
-
EBITDA
$92.83 K (USD)26.06as on Sep 30, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
6
as on Sep 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of InVitro International
InVitro International is a publicly listed company on the OTC with ticker symbol IVRO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of InVitro International
InVitro International offers a comprehensive portfolio of products and services, including IRRITECTION Assay System, Corrositex, and Lab Services.
Quantitative method for predicting ocular and dermal irritancy of chemicals
Non-animal test for classifying skin corrosives under GHS standards
Customized services using in vitro data for toxicity assessments
Funding Insights of InVitro International
Detailed funding history for InVitro International
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by InVitro International
Investment portfolio details for InVitro International
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - InVitro International
Detailed financials for InVitro International
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Invitro International Comparisons
Peer comparison for InVitro International
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of InVitro International
InVitro International operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nautilus Biotechnology, Somalogic, ProteinSimple, Amunix and Dynamic Biosensors, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
A proteomics platform is developed for analyzing the human proteome.
|
|
| Locked | Locked | Locked |
Protein-based assays are developed for life science research.
|
|
| Locked | Locked | Locked |
Provider tools to help researchers with protein analysis
|
|
| Locked | Locked | Locked |
Peptide-based therapeutics are developed for cancers and immune disorders.
|
|
| Locked | Locked | Locked |
Label-free solutions for molecular interactions and biophysical analysis are provided.
|
|
| Locked | Locked | Locked |
Proteomics services are delivered via discovery and targeted platforms.
|
Detailed competitors of InVitro International
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Invitro International
Complete news archive for InVitro International
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about InVitro International
InVitro International was founded in 1996.
InVitro International is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
As of Sep 30, 2024, the latest employee count at InVitro International is 6.
Annual revenue of InVitro International is $878.94K as on Sep 30, 2025.
InVitro International (IVRO) is a company focused on developing and marketing non-animal toxicity testing quantitative in-vitro tests for detection of ocular andor dermal irritants and corrosives. The company offers two detection tests and customized technology services (CTS). Its products : Irritection Assay System is a quantity test to detect, rank, and predict the ocular andor dermal irritants from either cosmetics, pharmaceuticals or any other consumer products while Corrositex test involves a biomembrane and chemical detection system that helps in determining the chemical corrosivity by becoming colored after chemical exposure. The company also provide consultancy services to their customers for the easy and smooth installation of the detection systems.
InVitro International's top competitors include Somalogic, Nautilus Biotechnology and Elektrofi.
InVitro International offers IRRITECTION Assay System, Corrositex, and Lab Services.
Yes, InVitro International is publicly traded on OTC under the ticker symbol IVRO.
The ticker symbol of InVitro International is IVRO on OTC.